Abiomed, Inc. ABMD
Set alert
381.02 +381.02 —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 17.18B
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- 60.77
- Beta
- 0.00
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 2, 2023
- 50-d avg
- 351.42
- 200-d avg
- 291.67
- 1y target
- 0.00
MAX chart
Events in this range
- Feb 3, 2022Earnings: —; estimate 0.98; surprise —%
- Apr 28, 2022Earnings: —; estimate 1.08; surprise —%
- Aug 4, 2022Earnings: —; estimate 1.08; surprise —%
- Oct 9, 2022Rating: Piper Sandler · — → Overweight
- Oct 12, 2022Rating: Mizuho · — → Buy
- Oct 31, 2022Downgrade: William Blair · Outperform → Market Perform
- Oct 31, 2022Downgrade: Piper Sandler · Overweight → Neutral
- Nov 1, 2022Earnings: —; estimate 1.05; surprise —%
- Nov 1, 2022Rating: Morgan Stanley · Underweight → Equal-Weight
- Nov 1, 2022Downgrade: Deutsche Bank · Buy → Hold
Signals (17)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Nov 8, 2022 | 3 years ago |
| SMA: Bullish | Nov 8, 2022 | 3 years ago |
| SMA: Bearish | Oct 31, 2022 | 4 years ago |
| SMA: Bullish | Oct 24, 2022 | 4 years ago |
| MACD: Buy Signal | Oct 17, 2022 | 4 years ago |
| MACD: Sell Signal | Oct 10, 2022 | 4 years ago |
| SMA: Bearish | Sep 19, 2022 | 4 years ago |
| SMA: Bearish | Sep 19, 2022 | 4 years ago |
| SMA: Bullish | Sep 12, 2022 | 4 years ago |
| SMA: Bullish | Sep 12, 2022 | 4 years ago |
| SMA: Bearish | Aug 22, 2022 | 4 years ago |
| SMA: Bearish | Aug 22, 2022 | 4 years ago |
| SMA: Bullish | Aug 1, 2022 | 4 years ago |
| MACD: Buy Signal | Jul 11, 2022 | 4 years ago |
| SMA: Bullish | Jul 1, 2022 | 4 years ago |
| SMA: Bearish | Apr 11, 2022 | 4 years ago |
| SMA: Bullish | Mar 21, 2022 | 4 years ago |
Financial health
Altman Z-Score
68.84 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
5 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E 110×
FY 2013 5y median 63.7× FY 2022
P/S 14.6×
FY 2013 5y median 16.2× FY 2022
P/B 10.0×
FY 2013 5y median 10.8× FY 2022
P/FCF 60.3×
FY 2013 5y median 60.3× FY 2022
EV/EBITDA 29.8×
FY 2013 5y median 53.5× FY 2022
EV/Sales 14.5×
FY 2013 5y median 16.1× FY 2022
FCF Yield 1.7%
FY 2013 5y median 1.7% FY 2022
Profitability
Gross Margin 81.8%
FY 2013 5y median 82.0% FY 2022
Operating Margin 36.1%
FY 2013 5y median 29.2% FY 2022
Net Margin 13.2%
FY 2013 5y median 24.1% FY 2022
ROE 9.1%
FY 2013 5y median 17.0% FY 2022
ROIC 17.4%
FY 2013 5y median 17.0% FY 2022
ROA 8.2%
FY 2013 5y median 15.1% FY 2022
Growth (YoY)
Revenue 21.7%
FY 2013 FY 2022
Operating Income 62.4%
FY 2013 FY 2022
EPS (diluted) -39.7%
FY 2013 FY 2022
Free Cash Flow 12.9%
FY 2013 FY 2022
Financial Health
Current Ratio 7.1×
FY 2013 5y median 6.1× FY 2022
Quick Ratio 6.4×
FY 2013 5y median 5.5× FY 2022
Debt / Equity 0.0×
FY 2013 5y median 0.0× FY 2022
Net Debt / EBITDA -0.3×
FY 2013 5y median -0.5× FY 2022
Interest Coverage 7.5×
FY 2013 5y median 0.0× FY 2022
Dividends
Dividend Yield 0.0%
FY 2013 5y median 0.0% FY 2022
Payout Ratio 0.0%
FY 2013 5y median 0.0% FY 2022
Annual · latest fiscal year ends 2022-03-31